Inventor · disambiguated record
Nan Ji
Also filed as: JI NAN
49 granted patents·34 pending applications·405 citations·filing 2009–2025
98Inventor score
Files withKYMERA THERAPEUTICS INC43ARTMAN III GERALD DAVID6MITOBRIDGE INC6ADAMS CHRISTOPHER MICHAEL5HONG KONG CENTRE FOR CEREBRO CARDIOVASCULER HEALTH ENGINEERING LTD4
Top patents by PatentIndex Score
83 records- 0198US11746120B2Stat degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Sep 5, 2023·12 cites·30 claims
- 0298US11723980B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Aug 15, 2023·9 cites·14 claims
- 0398US11485750B1STAT degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2020·Granted Nov 1, 2022·7 cites·20 claims
- 0498US11117889B1IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2020·Granted Sep 14, 2021·28 cites·28 claims
- 0598US10874743B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2018·Granted Dec 29, 2020·38 cites·20 claims
- 0697US12258341B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Granted Mar 25, 2025·5 cites·18 claims
- 0797US12168057B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Granted Dec 17, 2024·5 cites·17 claims
- 0897US12077555B2STAT degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Sep 3, 2024·3 cites·14 claims
- 0997US11807636B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Nov 7, 2023·6 cites·19 claims
- 1097US11292792B2Tricyclic CRBN ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2019·Granted Apr 5, 2022·19 cites·15 claims
- 1196US12006329B2Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Jun 11, 2024·4 cites·9 claims
- 1296US11512080B2CRBN ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2019·Granted Nov 29, 2022·15 cites·20 claims
- 1396US11358948B2CRBN ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2018·Granted Jun 14, 2022·16 cites·16 claims
- 1496US11352350B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2019·Granted Jun 7, 2022·20 cites·11 claims
- 1596US9056874B2Complement pathway modulators and uses thereofADAMS CHRISTOPHER MICHAEL·Filed 2013·Granted Jun 16, 2015·95 cites·29 claims
- 1696US8501756B2Heterobicyclic carboxamides as inhibitors for kinasesARTMAN III GERALD DAVID·Filed 2012·Granted Aug 6, 2013·65 cites·3 claims
- 1795US11318205B1IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2020·Granted May 3, 2022·10 cites·14 claims
- 1894US12150995B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2021·Granted Nov 26, 2024·4 cites·15 claims
- 1994US11932624B2MDM2 degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Mar 19, 2024·2 cites·30 claims
- 2092US11932635B2CRBN ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Mar 19, 2024·1 cites·21 claims
- 2191US11897882B2Tricyclic crbn ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Feb 13, 2024·1 cites·19 claims
- 2291US10611790B2Nicotinamide riboside and nicotinamide mononucleotide derivatives for use in the treatments of mitochondrial-related diseasesMITOBRIDGE INC·Filed 2016·Granted Apr 7, 2020·11 cites·17 claims
- 2390US11623932B2Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2018·Granted Apr 11, 2023·3 cites·13 claims
- 2489US11485743B2Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2019·Granted Nov 1, 2022·6 cites·8 claims
- 2587US2025000985A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2685US2025059221A1Stat degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2783US11034670B2Poly-ADP ribose polymerase (PARP) inhibitorsMITOBRIDGE INC·Filed 2017·Granted Jun 15, 2021·2 cites·30 claims
- 2882US12378200B2Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitorsORSOBIO INC·Filed 2023·Granted Aug 5, 2025·0 cites·36 claims
- 2981US9676728B22-benzyl-benzimidazole complement factor B inhibitors and uses thereofADAMS CHRISTOPHER·Filed 2014·Granted Jun 13, 2017·6 cites·12 claims
- 3081US2025051320A1Crbn ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3180US9475806B2Complement factor B inhibitors and uses there ofADAMS CHRISTOPHER MICHAEL·Filed 2014·Granted Oct 25, 2016·6 cites·14 claims
- 3280US8242125B2Heterobicyclic carboxamides as inhibitors for kinasesARTMAN III GERALD DAVID·Filed 2009·Granted Aug 14, 2012·3 cites·19 claims
- 3380US2025042902A1Tricyclic crbn ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3475US12454520B2Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2019·Granted Oct 28, 2025·1 cites·16 claims
- 3575US2025121073A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3675US2025325673A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3774US8846656B2Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulatorsADAMS CHRISTOPHER MICHAEL·Filed 2012·Granted Sep 30, 2014·2 cites·3 claims
- 3874US2025163042A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3973US2025388566A1Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4073US2023115184A1Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4172US2025145572A1Aminocarboxymuconate Semialdehyde Decarboxylase (ACMSD) InhibitorsORSOBIO INC·Filed 2025·Application pending·0 cites
- 4271US2023303526A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4371US2024059674A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4470US11780812B2Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitorsORSOBIO INC·Filed 2020·Granted Oct 10, 2023·0 cites·18 claims
- 4569US12404285B2KRAS G12D proteolysis targeting chimerasPAQ THERAPEUTICS INC·Filed 2024·Granted Sep 2, 2025·0 cites·30 claims
- 4669US2025051364A1KRAS G12D Proteolysis Targeting ChimerasPAQ THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4766US11993585B2Poly-ADP ribose polymerase (PARP) inhibitorsMITOBRIDGE INC·Filed 2021·Granted May 28, 2024·0 cites·20 claims
- 4863US2025214969A1Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4962US8541432B2Heterobicyclic carboxamides as inhibitors for kinasesARTMAN III GERALD DAVID·Filed 2012·Granted Sep 24, 2013·0 cites·3 claims
- 5062US8492393B2Heterobicyclic carboxamides as inhibitors for kinasesARTMAN III GERALD DAVID·Filed 2012·Granted Jul 23, 2013·0 cites·6 claims
Showing the top 50 of 83 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Nan Ji files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →